Keywords
How to Cite
Abstract
The article discusses the problem of venous thromboembolism, the question of the place of D-dimer in the hemostasis system and its clinical significance and the need for testing when examining patients with suspected venous thromboembolism. Considered conditions that are accompanied by an increase in the level of D-dimer, but not associated with venous thrombosis.
References
Tran H, Gibbs H, Merriman E. et al. New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. Med. J. 2019;210(5). doi: 10.5694/mja2.50004.
Tagalakis V, Patenaude V, Kahn S, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am. J. Med. 2013;126:832. e13-21.
Консенсус експертів щодо лікування пацієнтів із ТГВ згідно з сучасними світовими рекомендаціями / ЛМ Чернуха та члени робочої групи: ІМ Гудз, ІІ Кобза, МВ Костилєв, ЛФ Матюха, АО Никоненко, ОС Никоненко, ПІ Нікульников, ЮГ Орел, ОМ Пархоменко, ОО Сергєєв, ОМ Скупий, БМ Тодуров, ЯВ Хребтій. Київ. 06.05.2021.
ISTH Steering Committee for World Thrombosis Day. Venous thromboembolism: a call for risk assessment in all hospitalised patients. Thromb Haemost. 2016;116(5):777-779.
Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251(2):344-350.
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6):381S-453S.
Wells P, Anderson D, Bormanis J. et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet. 1997; 350:1795-8.
Caprini JA. Individual risk assessment is the best strategy for thromboembolic prophylaxis. DisMon. 2010;56(10):552-559.
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450-2457.
Autar R. Nursing assessment of clientsatrisk of deep vein thrombosis (DVT): the Autar DVT scale. J Adv Nurs. 1996;23(4):763-770.
Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352(10):969-977.
Gibson CM, Spyropoulos AC, Cohen AT, et al. The IMPROVEDD VTE Risk Score: In corporation of D-Dimer in to the IMPROVE Score to ImproveVenous Thromboembolism Risk Stratification. TH Open. 2017;1:e56-e65. doi:10.1055/s-0037-1603929.
Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):454-545.
Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, Lyman GH, Falanga A. Venous Thromboembolism Prophylaxis and Treatment in Patient With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2020 Feb 10;38(5):496-520. doi: 10.1200/JCO.19.01461. Epub2019 Aug 5. PMID: 31381464.